Company / Assets per Share
Catalyst Pharmaceuticals Partners, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.01
FY2025
5-year range
$2.31 / $9.01
FY2021-FY2025
Trend
+27.9%
vs FY2024
Sector context
#106 of 210
Health Care
What the data says
At $9.01, Catalyst Pharmaceuticals Partners, Inc.'s assets per share ranks #106 of 210 in the Health Care sector. Assets per Share has increased for 7 consecutive years, from $0.59 in FY2018 to $9.01 in FY2025.
Based on SEC 10-K filings.
9.01 in FY2025 with a 5-year CAGR of +37.1%.
Improved from $4.39 to $9.01 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +36.2%
- 5-Year CAGR
- +37.1%
- 10-Year CAGR
- -
Sector benchmark
#106 of 210 in Health CareTop 50% of 210This company $9.01 Sector average $352.89
▼
-97.4% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s assets per share has grown for 7 consecutive years.
- In FY2025, assets per share increased 27.9% year-over-year.
- Ranks #106 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.01 | +27.9% |
| FY2024 | $7.04 | +60.5% |
| FY2023 | $4.39 | +23.0% |
| FY2022 | $3.57 | +54.6% |
| FY2021 | $2.31 | +24.1% |
| FY2020 | $1.86 | +70.1% |
| FY2019 | $1.09 | +85.6% |
| FY2018 | $0.59 | -42.7% |
| FY2017 | $1.03 | +104.7% |
| FY2016 | $0.50 | -30.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026